Nottingham Trent University
Nottingham, Nottinghamshire, Ng11 8NS, United Kingdom
NCT Number: NCT06282705
The study aims to assess if a 16-week drop jump intervention from different heights shows different bone adaptations. Participants will complete four visits over a period of 16 weeks. An initial consultation will be conducted to ensure participants meet the inclusion criteria following participant recruitment. Estimated load being applied to the bone, will be assessed using non-invasive biomechanical procedures (Inertial Measurement Units, motion analysis, force plates) during drop jumps. Participants will be assigned a drop jump height of 0 cm, 30 cm or 60 cm based on a significant difference in external load at these heights or assigned to a control group where no jumps will be performed. Groups will be matched for body mass to ensure that jump height produces the load. The participants will be asked to perform 40 jumps (20 each side), 4 times per week ensuring jumping bouts are separated by 24 hours. Bone characteristics will be assessed via whole body dual-energy X-ray absorptiometry (DXA) scans and bilateral peripheral Quantitative Computed Tomography (pQCT) scans. Lab based jumping will take place on week 0, week 6, week 12, and week 16 to understand the loading applied during the different jump height groups. pQCT scans will take place on week 0, week 12, week 16 and DXA scans will take place week 0 and week 16. The reasoning of week 12 for pQCT being it may show a significant timepoint for bone formation during the remodelling cycle. During visits participants will complete a health screen, the Bone specific Physical Activity Questionnaire (BPAQ), a food frequency questionnaire and Pittsburgh sleep quality questionnaire alongside consent as tools to monitor any changes to participant lifestyle across the study. Differences in bone characteristics, lab measures and jump heights will be analysed between and within participants.
The present study aims to use varied drop jump heights to identify an osteogenic dose response effect. Drop jumps have been previously used to expose osteogenic effects in research due to the load produced at impact. Is it possible to identify an optimum height for bone response during impact? If so do we then find anything above this height actually has negative or no effect on a group of individuals?
Looking for future studies?
Notify Me18 year–25 year
All sexes
Interventional
Not applicable
Nottingham, Nottinghamshire, Ng11 8NS, United Kingdom
There are few studies that attempt to identify optimal exercises for bone health with specific loading variables being quantified. The identification of an osteogenic threshold during single or multiple activity bouts would allow us to understand the optimal volume/magnitude of exercise/loading that causes an osteogenic response. Understanding the optimal exercise characteristics for osteogenesis will subsequently allow specific bone enhancing exercise to be prescribed. Currently, ambiguity exists as in the guidance for optimising bone health through exercise, for example, a recently published position statement on increasing peak bone mass in adolescents recommends that 5-6 months of vigorous physical activity should be performed but does not quantify the specific speed or intensity of activity required.
pQCT and DXA will be used to measure bone characteristics. Both methods are a common way of obtaining data detailing bone architecture and geometry within established research establishments including universities and National Health Service (NHS) trusts. Through pQCT, bone geometry, both cortical and trabecular bone can be measured and as a result, bone quality can be assessed. Bone measurement via pQCT is widely used in research and is a non-invasive method of imaging bone to provide estimates of bone strength in the peripheral skeleton to differentiate cortical from trabecular bone and assess bone geometry and density. DXA is the gold standard method of measuring bone mineral density and is commonly used to assess osteoporosis risk.
In addition, body composition (which will be derived from the DXA) may be associated with bone characteristics due to body mass and composition relating to bone loading and muscle acting on bone to produce bone strain.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Participants will complete 4 unsupervised home drop jump sessions per week ( minimum 24 hours between each session) for the duration of the study (e.g., Mon, Wed, Fri, Sun) from a height of 0 cm (floor). They will perform 20 diagonal drop jumps on each side (20 x dropping left and 20 x dropping right) with 30 seconds between each jump. The routine will be demonstrated in full on the first laboratory session. The intervention will last 16 weeks.
Participants will complete 4 unsupervised home drop jump sessions per week ( minimum 24 hours between each session) for the duration of the study (e.g., Mon, Wed, Fri, Sun) from a height of 40 cm (plyo box). They will perform 20 diagonal drop jumps on each side (20 x dropping left and 20 x dropping right) with 30 seconds between each jump. The routine will be demonstrated in full on the first laboratory session. The intervention will last 16 weeks.
Participants will complete 4 unsupervised home drop jump sessions per week ( minimum 24 hours between each session) for the duration of the study (e.g., Mon, Wed, Fri, Sun) from a height of 60 cm (plyo box). They will perform 20 diagonal drop jumps on each side (20 x dropping left and 20 x dropping right) with 30 seconds between each jump. The routine will be demonstrated in full on the first laboratory session. The intervention will last 16 weeks.
Time frame: From baseline (week 0) to end of intervention (week 16)
Bone mineral density (BMD)
Time frame: From baseline (week 0) to end of intervention (week 16)
Bone mineral content (BMC)
Time frame: From baseline (week 0) to end of intervention (week 16)
Total bone area
Time frame: From baseline (week 0) to mid intervention (week 12) and end of intervention (week 16)
Trabecular density measured at the 4% site of the tibia length.
Time frame: From baseline (week 0) to mid intervention (week 12) and end of intervention (week 16)
Cortical thickness measured at the 14% and 38% site of the tibial length.
Time frame: From baseline (week 0) to mid intervention (week 12) and end of intervention (week 16)
Periosteal circumference measured at the 14% and 38% site of the tibial length.
Time frame: From baseline (week 0) to mid intervention (week 12) and end of intervention (week 16)
SSIX measured at the 14% and 38% site of the tibial length.
Time frame: From baseline (week 0) to mid intervention (week 12) and end of intervention (week 16)
SSIY measured at the 14% and 38% site of the tibial length.
Time frame: From baseline (week 0) to mid intervention (week 12) and end of intervention (week 16)
SSIPOL measured at the 14% and 38% site of the tibial length.
Time frame: From baseline (week 0) to mid intervention (week 12) and end of intervention (week 16)
Cortical density measured at the 14%, 38% and 66% site of the tibial length.
Time frame: From baseline (week 0) to mid intervention (week 6, week 12) and end of intervention (week 16)
Peak impact load derived from ground reaction force (GRF)
Time frame: From baseline (week 0) to mid intervention (week 6, week 12) and end of intervention (week 16)
Impulse derived from ground reaction force (GRF)
Time frame: From baseline (week 0) to mid intervention (week 6, week 12) and end of intervention (week 16)
Load rate derived from ground reaction force (GRF)
Time frame: From baseline (week 0) to mid intervention (week 6, week 12) and end of intervention (week 16)
Jump height derived from ground reaction force (GRF)
Time frame: From baseline (week 0) to mid intervention (week 6, week 12) and end of intervention (week 16)
CoM velocity derived from ground reaction force (GRF)
Time frame: From baseline (week 0) to mid intervention (week 6, week 12) and end of intervention (week 16)
Peak accelerations calculated from tibial mounted IMUs.
Time frame: From baseline (week 0) to mid intervention (week 6, week 12) and end of intervention (week 16)
Knee and ankle Stiffness derived from motion capture.
Time frame: From baseline (week 0) to mid intervention (week 6, week 12) and end of intervention (week 16)
Knee and ankle moments derived from motion capture.
Nottingham Trent University
Other
Is There a Dose-response Effect on Bone Characteristics in Relation to Drop Jump Height?
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05870072
Balance, Postural, Behavior
Kütahya, Centre, Turkey (Türkiye)
View Trial DetailsNCT07241065
Healthy Participants
Berlin, Germany
View Trial DetailsNCT07214766
Healthy Participants
Anaheim, California, United States
View Trial DetailsNCT07444424
Body Weight, Diabetes Mellitus
Fukuoka, Japan
View Trial Details